Premium
The challenges of ‘medical cannabis’ and mental health: a clinical perspective
Author(s) -
NewtonHowes Giles
Publication year - 2018
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.13687
Subject(s) - cannabis , medical prescription , medical cannabis , psychiatry , medicine , cannabinoid , effects of cannabis , alternative medicine , mental health , pharmacopoeia , perspective (graphical) , traditional medicine , pharmacology , cannabidiol , receptor , pathology , artificial intelligence , computer science
The use of cannabis as a medicine has a long tradition in Western medicine. It has been seen as a viable option for the treatment of various neurological and psychiatric conditions, and recently there is again interest in the place of cannabinoids in the pharmacopoeia. What has become increasingly clear, however, is these benefits need to be weighed carefully against the potential difficulty associated with herbal cannabis and cannabinoid compounds for an individual's mental health. This challenges the use of cannabis as a medication and the regulation of its prescription.